Add-on Acquisition • Life Science

IBX Acquires Roylance Pharma

On September 15, 2021, IBX acquired life science company Roylance Pharma

Acquisition Context

This is IBX’s 1st transaction in the Life Science sector.
This is IBX’s 1st transaction in the United Kingdom.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	September 15, 2021
Target	Roylance Pharma
Sector	Life Science
Buyer(s)	IBX
Deal Type	Add-on Acquisition

Target Company

Roylance Pharma

Macclesfield, United Kingdom

Roylance Pharma specialists in biobanking and stability storage of pharmaceutical and biological samples with a combined experience of over 50 years specifically in sample storage services. Processes have been built from the ground up with state-of-the-art facilities, validation, sops, and quality systems. Roylance Pharma is based in Macclesfield, United Kingdom.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

IBX

Piscataway, New Jersey, United States

Category	Company
Sector	Life Science

DESCRIPTION

IBX is biobanking, bioprocessing, and analytics company that provides global sample collection, processing, storage, and analytical services integrated with scientific and technical support in both the research and clinical arenas. IBX is based in Piscataway, New Jersey.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: United Kingdom	1 of 1
Year: 2021	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - United Kingdom M&A - 2021 M&A